This inventor holds 1 USPTO granted patent. Top assignee: Northwestern University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Iredia D Iyamu: Innovator in Medicinal Chemistry
Introduction
Iredia D Iyamu is a notable inventor based in Evanston, IL (US). He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on small molecule modulators of sigma-1 and sigma-2 receptors. His research focuses on developing new therapeutic options for various diseases, including cancer and neurological conditions.
Latest Patents
Iredia D Iyamu holds 1 patent for his invention titled "Small molecule modulators of sigma-1 and sigma-2 receptors and uses thereof." This invention introduces a new class of small molecules characterized by a tetrahydroindazole structure. These molecules function as modulators, either activating or inhibiting sigma-1 and/or sigma-2 receptors, which are crucial in the treatment of diseases associated with these receptors.
Career Highlights
Iredia D Iyamu is affiliated with Northwestern University, where he continues to advance his research in medicinal chemistry. His work has the potential to lead to groundbreaking therapies that address significant health challenges.
Collaborations
Iredia has collaborated with esteemed colleagues such as Gary E Schiltz and Rama K Mishra, contributing to a rich environment of innovation and research.
Conclusion
Iredia D Iyamu's contributions to medicinal chemistry exemplify the impact of innovative research on healthcare. His work on sigma receptor modulators holds promise for developing new treatments for cancer and neurological diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile